10 December 1999
Carbon Fiber Scaffolds in the Surgical Treatment of Cartilage Lesions
W M Kus, A Gorecki, P Strzelczyk, P SwiaderAnn Transplant 1999; 4(3-4): 101-102 :: ID: 497496
Abstract
We present a new method of treatment of chondral defects of the knee with the usage of carbon fibers. The prospective study describes experience with carbon fibers used as scaffolds in the drilled lesions to enhance ingrowth of regenerative tissue. We treated 35 patients for chondral defects with that method from December 93 to June 97. Average age was 46 years (range, 19-68 years) and average follow-up was 48 months (range, 24-55 months). The results were assessed by HSSknee scale, the Wallgren-Tegner activity score, VAS(visual analogue scale to measure pain) and patients assessment of the surgery. Twenty-fIVe (71%) of 35 patients were rated good or excellent. The most striking result was good pain relief. Early follow-up results are good, but these must be confirmed in long-term observations.
Keywords: carbon fibres,, joint resurfacing, Knee
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






